Powder: -20°C for 3 years | In solvent: -80°C for 1 year
N-Trifluoroacetyladriamycin is a metabolite of Valrubicin (N-trifluoroacetyladriamycin-14-valerate, trade name Valstar). Valrubicin is a chemotherapy drug utilized to treat bladder cancer. Valrubicin is the anthracycline doxorubicin analog and is administered by infusion directly into the bladder.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 523.00 |
Description | N-Trifluoroacetyladriamycin is a metabolite of Valrubicin (N-trifluoroacetyladriamycin-14-valerate, trade name Valstar). Valrubicin is a chemotherapy drug utilized to treat bladder cancer. Valrubicin is the anthracycline doxorubicin analog and is administered by infusion directly into the bladder. |
Synonyms | NSC-283464, NSC 283464, AD 41, AD-41, NSC283464 |
Molecular Weight | 639.533 |
Formula | C29H28F3NO12 |
CAS No. | 26295-56-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
N-Trifluoroacetyladriamycin 26295-56-7 NSC-283464 NSC 283464 AD41 N Trifluoroacetyladriamycin NTrifluoroacetyladriamycin AD 41 AD-41 NSC283464 inhibitor inhibit